These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 34239494)

  • 1. The Pharmacoresistant Epilepsy: An Overview on Existent and New Emerging Therapies.
    Fattorusso A; Matricardi S; Mencaroni E; Dell'Isola GB; Di Cara G; Striano P; Verrotti A
    Front Neurol; 2021; 12():674483. PubMed ID: 34239494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure to use new breakthrough treatments for epilepsy.
    Klein P; Krauss GL; Steinhoff BJ; Devinsky O; Sperling MR
    Epilepsia; 2023 Jun; 64(6):1458-1465. PubMed ID: 36855241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy for Dravet Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
    Lattanzi S; Trinka E; Russo E; Del Giovane C; Matricardi S; Meletti S; Striano P; Damavandi PT; Silvestrini M; Brigo F
    Drugs; 2023 Oct; 83(15):1409-1424. PubMed ID: 37695433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying key unmet needs and value drivers in the treatment of focal-onset seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through Multi-Criteria Decision Analysis (MCDA).
    Villanueva V; Carreño M; Gil-Nagel A; Serrano-Castro PJ; Serratosa JM; Toledo M; Álvarez-Barón E; Gil A; Subías-Labazuy S
    Epilepsy Behav; 2021 Sep; 122():108222. PubMed ID: 34371462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spanish consensus on the management of concomitant antiseizure medications when using cenobamate in adults with drug-resistant focal seizures.
    Carreño M; Gil-Nagel A; Serratosa JM; Toledo M; Rodriguez-Uranga JJ; Villanueva V
    Epilepsia Open; 2024 Jun; 9(3):1051-1058. PubMed ID: 38573131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond.
    Löscher W; Klein P
    CNS Drugs; 2021 Sep; 35(9):935-963. PubMed ID: 34145528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication.
    Strzelczyk A; Schubert-Bast S
    CNS Drugs; 2022 Mar; 36(3):217-237. PubMed ID: 35156171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The latest advances in the pharmacological management of focal epilepsies in children: a narrative review.
    Matricardi S; Scorrano G; Prezioso G; Burchiani B; Di Cara G; Striano P; Chiarelli F; Verrotti A
    Expert Rev Neurother; 2024 Apr; 24(4):371-381. PubMed ID: 38433525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies.
    Reddy DS
    Exp Neurol; 2023 Jan; 359():114237. PubMed ID: 36206806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA).
    Falip M; López González FJ; Martín-Herranz I; Merino-Bohórquez V; Montoya J; Rey Gómez-Serranillos I; Rodriguez Uranga JJ; Ruiz E; Sancho-López A; Trillo Mata JL; Antoni Vallès J; Álvarez-Barón E; Sabaniego J; Subías-Labazuy S; Gil A
    Epilepsy Behav; 2023 Aug; 145():109350. PubMed ID: 37480633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to subsequent antiseizure medications after first antiseizure medication failure in newly diagnosed epilepsy.
    Hersi H; Saarinen JT; Raitanen J; Peltola J
    Front Neurol; 2022; 13():1042168. PubMed ID: 36438960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retention, efficacy, tolerability, and quality of life during long-term adjunctive brivaracetam treatment by number of lifetime antiseizure medications: A post hoc analysis of phase 3 trials in adults with focal seizures.
    Brandt C; Dimova S; Elmoufti S; Laloyaux C; Nondonfaz X; Klein P
    Epilepsy Behav; 2023 Jan; 138():108967. PubMed ID: 36435010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New paradigms for the treatment of pediatric monogenic epilepsies: Progressing toward precision medicine.
    Specchio N; Pietrafusa N; Perucca E; Cross JH
    Epilepsy Behav; 2022 Jun; 131(Pt B):107961. PubMed ID: 33867301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies.
    Strzelczyk A; Schubert-Bast S
    CNS Drugs; 2022 Oct; 36(10):1079-1111. PubMed ID: 36194365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.
    Gil-Nagel A; Falip M; Sánchez-Carpintero R; Abad-Sazatornil MR; Poveda JL; Aibar JÁ; Cardenal-Muñoz E; Aras LM; Sánchez R; Sancho-López A; Trillo-Mata JL; Torrejón M; Gil A
    Epilepsy Behav; 2022 Jul; 132():108711. PubMed ID: 35588562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural product-derived therapies for treating drug-resistant epilepsies: From ethnopharmacology to evidence-based medicine.
    Challal S; Skiba A; Langlois M; Esguerra CV; Wolfender JL; Crawford AD; Skalicka-Woźniak K
    J Ethnopharmacol; 2023 Dec; 317():116740. PubMed ID: 37315641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment simplification to optimize cenobamate effectiveness and tolerability: A real-world retrospective study in Spain.
    Rodríguez-Uranga JJ; Sánchez-Caro JM; Hariramani Ramchandani R
    Epilepsia Open; 2024 Aug; 9(4):1345-1356. PubMed ID: 38800945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolution of antiseizure medication therapy selection in adults: Is artificial intelligence -assisted antiseizure medication selection ready for prime time?
    Gunasekera CL; Sirven JI; Feyissa AM
    J Cent Nerv Syst Dis; 2023; 15():11795735231209209. PubMed ID: 37868934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A complex systems view on the current hypotheses of epilepsy pharmacoresistance.
    Servilha-Menezes G; Garcia-Cairasco N
    Epilepsia Open; 2022 Aug; 7 Suppl 1(Suppl 1):S8-S22. PubMed ID: 35253410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose Adjustment of Concomitant Antiseizure Medications During Cenobamate Treatment: Expert Opinion Consensus Recommendations.
    Smith MC; Klein P; Krauss GL; Rashid S; Seiden LG; Stern JM; Rosenfeld WE
    Neurol Ther; 2022 Dec; 11(4):1705-1720. PubMed ID: 36057761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.